Drug Trial Radar · NCT06463028
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Last checked: Nov 19, 2026Latest source record: Dec 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Dec 12, 2024
Primary completion
Sep 2028
Study completion Sep 2029
Sponsor
- Lead sponsor
- Faeth TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- GOG Foundation
- First posted
- Jun 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, multicenter, open-label, single-arm study to evaluate the efficacy and safety of sapanisertib and serabelisib (PIKTOR) with paclitaxel in participants with advanced or recurrent endometrial cancer.
Conditions
- Endometrial Cancer
Interventions
SapanisertibDrug
Oral
SerabelisibDrug
Oral
PaclitaxelDrug
Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: Up to 2 years
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
UC San Diego Moores Cancer Center
La Jolla, California · Recruiting
University of California, San Francisco (UCSF)
San Francisco, California · Recruiting
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida · Recruiting
Florida Cancer Specialists, North
St. Petersburg, Florida · Recruiting
Florida Cancer Specialists, East
West Palm Beach, Florida · Recruiting
Maryland Oncology Hematology, P.A.
Brandywine, Maryland · Recruiting
Minnesota Oncology Hematology, P.A.
Maple Grove, Minnesota · Recruiting
Women's Cancer Care Associates, LLC
Albany, New York · Recruiting
Memorial Sloan Kettering Cancer Center
New York, New York · Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio · Recruiting
Oncology Associates of Oregon, P.C.
Eugene, Oregon · Recruiting
Northwest Cancer Specialists, P.C.
Portland, Oregon · Recruiting
Alliance Cancer Specialists, PC
Doylestown, Pennsylvania · Recruiting
West Penn Hospital
Pittsburgh, Pennsylvania · Recruiting
Avera Cancer Institute
Sioux Falls, South Dakota · Recruiting
Texas Oncology - West Texas
El Paso, Texas · Recruiting
Texas Oncology - Gulf Coast
The Woodlands, Texas · Recruiting
Virginia Cancer Specialists, P.C.
Fairfax, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.